Joshua Apgar

Company: Applied BioMath

Job title: Co-Founder & Chief Scientific Officer

Seminars:

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies 12:15 pm

• Streamlining therapeutic index-focused discovery and drug development for TRTs with clinical pharmacology considerations and model-informed drug development (MIDD) concepts • Understanding dose optimization requirements for TRT in the clinical pharmacology regulatory landscape while complying with the FDA’s Project Optimus initiative to optimize oncology drug dosage • Discover how MIDD, including quantitative systems pharmacology (QSP)…Read more

day: Day One Discovery AM